Literature DB >> 11789979

Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents.

P Rotariu1, P Yohannes, M Alexianu, D Rosner, B R Lee, M Lucan, A D Smith.   

Abstract

BACKGROUND AND
PURPOSE: Extrinsic ureteral obstruction caused by various malignancies often necessitates urinary diversion. The use of single ureteral stents as a form of urinary diversion results in a high failure rate, while the use of two ipsilateral stents has shown promising results. We report our experience using the latter technique. PATIENTS AND METHODS: Between 1996 and 2001, four male and three female patients with a mean age of 65 years (range 37-95 years) who had extrinsic compression of the ureters underwent single stent management to relieve obstruction. Ureteral obstruction was secondary to prostate cancer (N = 3), cervical cancer (2), non-Hodgkin's lymphoma (1), and transitional-cell cancer of the bladder and ureter (1). After failure of such management, two 7F stents or a combination of 8F/6F double-J ureteral stents were placed. The stents were changed every 4 to 6 months. Follow-up included serial renal ultrasound scans and serum creatinine measurements.
RESULTS: Ureteral stricture length ranged from 2 to 4 cm. Insertion of two double-J ureteral stents in a single ureter was successful in all cases. During the mean follow-up of 16 months (range 1-38 months), the ureteral stents were tolerated by all patients, without significant discomfort. Marked improvement of hydronephrosis and alleviation of flank pain was noted in all patients. Three patients have died at 1 to 3 months. Renal function improved, with a mean decline in the serum creatinine concentration from 3.2 mg/dL to 1.48 mg/dL in the five patients tested.
CONCLUSION: Simultaneous placement of two double-J ureteral stents for the management of ureteral obstruction secondary to a malignancy is a safe and effective technique.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11789979     DOI: 10.1089/089277901317203047

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  16 in total

Review 1.  [Treatment of specific complications of locally advanced prostate cancer].

Authors:  F C von Rundstedt; A S Brandt; D Lazica; M J Mathers; S Roth
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

2.  Update on ureteral stent technology.

Authors:  Dirk Lange; Ben H Chew
Journal:  Ther Adv Urol       Date:  2009-08

3.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

4.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

5.  [Duplex ureteral stenting for intrinsic and extrinsic ureteral strictures: an effective and elegant alternative].

Authors:  F-C von Rundstedt; D Lazica; A S Brandt; M Rathert; S Roth
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 6.  Endoscopic Management of Ureteral Strictures: an Update.

Authors:  Jacob W Lucas; Eric Ghiraldi; Jeffrey Ellis; Justin I Friedlander
Journal:  Curr Urol Rep       Date:  2018-03-02       Impact factor: 3.092

7.  Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.

Authors:  Kao-Lang Liu; Bo-Ching Lee; Jian-De Ye; Yu-Hsuan Chang; Chin-Chen Chang; Kuo-How Huang; Yuan-Ju Lee; Yeun-Chung Chang
Journal:  Eur Radiol       Date:  2018-07-04       Impact factor: 5.315

Review 8.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

9.  Aggressive approach in a case of cancer cervix with uremia.

Authors:  Mg Janaki; S Mukesh; Tr Arul Ponni; S Nirmala
Journal:  Indian J Palliat Care       Date:  2010-01

10.  Endoscopic realignment in the management of complete transected ureter.

Authors:  Chunlai Liu; Xiling Zhang; Dongwei Xue; Yili Liu; Ping Wang
Journal:  Int Urol Nephrol       Date:  2013-08-08       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.